We Analyzed the Future Direction of Voyager Therapeutics Inc. (VYGR), Here is What We Found – News Heater
Home  »  Business   »  We Analyzed the Future Direction of Voyager Therap...

We Analyzed the Future Direction of Voyager Therapeutics Inc. (VYGR), Here is What We Found

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

Voyager Therapeutics Inc. (NASDAQ:VYGR) went up by 1.25% from its latest closing price compared to the recent 1-year high of $9.69. The company’s stock price has collected -5.56% of loss in the last five trading sessions. Press Release reported on 11/19/21 that Voyager Therapeutics Announces Positive Preclinical Data from New Vectorized anti-HER2 Antibody Program at the 26th Society for Neuro-Oncology Annual Meeting

Is It Worth Investing in Voyager Therapeutics Inc. (NASDAQ :VYGR) Right Now?

Plus, the 36-month beta value for VYGR is at 1.19. Opinions of the stock are interesting as 3 analysts out of 10 who provided ratings for Voyager Therapeutics Inc. declared the stock was a “buy,” while 1 rated the stock as “overweight,” 6 rated it as “hold,” and 0 as “sell.”


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


The average price from analysts is $6.86, which is $3.63 above the current price. VYGR currently public float of 32.70M and currently shorts hold a 7.35% ratio of that float. Today, the average trading volume of VYGR was 5.50M shares.

VYGR’s Market Performance

VYGR stocks went down by -5.56% for the week, with a monthly drop of -13.17% and a quarterly performance of 2.22%, while its annual performance rate touched -61.59%. The volatility ratio for the week stands at 8.69% while the volatility levels for the past 30 days are set at 7.01% for Voyager Therapeutics Inc.. The simple moving average for the period of the last 20 days is -8.59% for VYGR stocks with a simple moving average of -23.24% for the last 200 days.

Analysts’ Opinion of VYGR

Many brokerage firms have already submitted their reports for VYGR stocks, with Robert W. Baird repeating the rating for VYGR by listing it as a “Outperform.” The predicted price for VYGR in the upcoming period, according to Robert W. Baird is $9 based on the research report published on October 07th of the current year 2021.

Robert W. Baird, on the other hand, stated in their research note that they expect to see VYGR reach a price target of $6, previously predicting the price at $18. The rating they have provided for VYGR stocks is “Neutral” according to the report published on February 26th, 2021.

Wedbush gave a rating of “Neutral” to VYGR, setting the target price at $6 in the report published on February 03rd of the current year.

VYGR Trading at -9.22% from the 50-Day Moving Average

After a stumble in the market that brought VYGR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -66.67% of loss for the given period.

Volatility was left at 7.01%, however, over the last 30 days, the volatility rate increased by 8.69%, as shares sank -13.64% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +7.31% upper at present.

During the last 5 trading sessions, VYGR fell by -5.56%, which changed the moving average for the period of 200-days by -57.22% in comparison to the 20-day moving average, which settled at $3.51. In addition, Voyager Therapeutics Inc. saw -54.83% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at VYGR starting from Khwaja Omar, who sale 3,516 shares at the price of $4.03 back on May 21. After this action, Khwaja Omar now owns 120,509 shares of Voyager Therapeutics Inc., valued at $14,169 using the latest closing price.

Turenne Andre, the President & CEO of Voyager Therapeutics Inc., sale 7,977 shares at $7.55 during a trade that took place back on Feb 11, which means that Turenne Andre is holding 148,375 shares at $60,226 based on the most recent closing price.

Stock Fundamentals for VYGR

Current profitability levels for the company are sitting at:

  • +16.00 for the present operating margin

The net margin for Voyager Therapeutics Inc. stands at +21.47. The total capital return value is set at 16.32, while invested capital returns managed to touch 22.39. Equity return is now at value -76.00, with -41.60 for asset returns.

Based on Voyager Therapeutics Inc. (VYGR), the company’s capital structure generated 30.85 points at debt to equity in total, while total debt to capital is 23.58. Total debt to assets is 18.20, with long-term debt to equity ratio resting at 28.13. Finally, the long-term debt to capital ratio is 21.50.

>> 7 Top Picks for the Post-Pandemic Economy <<

When we switch over and look at the enterprise to sales, we see a ratio of -0.78, with the company’s debt to enterprise value settled at 0.36. The receivables turnover for the company is 12.77 and the total asset turnover is 0.56. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.39.

Sign up for our FREE Newsletter and get:

Leave a Comment

Your email address will not be published. Required fields are marked *

Sign up for our FREE Newsletter and get:

Is CTI BioPharma Corp. (CTIC) a Keeper?

CTI BioPharma Corp. (NASDAQ:CTIC) went up by 11.81% from its latest closing price compared to the recent 1-year high of $4.13. The company’s stock price

Heading

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

Heading

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam